Dr Maria Ashioti

Senior Lecturer

+44 20 7911 5000 ext 64130
115 New Cavendish Street London W1W 6UW

I'm part of

Life Sciences | Department

Connect with me

I am currently a senior lecturer in the department of Life Sciences at the University of Westminster.  My academic career began when I completed my undergraduate degree in Human Physiology at the University of Greenwich with a first class honours in 2002. During the final year of my degree, I developed a keen interest in neuroscience and in particular stroke research and decided to continue within academia. I undertook a MSc in Neuroscience at the Institute of Psychiatry, Kings College London and achieved a distinction in 2003.  My research interest in the field of neuroprotection for ischaemic stroke began to develop further and I embarked upon a PhD in 2003 within the department of pre-clinical MRI at the Institute of Psychiatry.  I completed my PhD in 2008 entitled 'A multimodal approach to assessing the neuroprotective efficacy of a novel 5-HT1A agonist in preclinical models of transient cerebral ischaemia'.  I remained within the department for a few months as a postdoctoral researcher before accepting a position as a lecturer at the University of Westminster. In 2011, I achieved the Postgraduate Certificate in Higher Education and become a fellow of the Higher Education Academy.  I am also the quality coordinator for the department of life sciences.

2013

Sulforaphane alters cerebral leukocyte endothelial cell interactions post global ischaemia reperfusion (2013)
Gillespie, S., Milton, N.G.N., Ashioti, M. and Gavins, F.N.E. 2013. Sulforaphane alters cerebral leukocyte endothelial cell interactions post global ischaemia reperfusion. FASEB Journal. 27, p. 687.18.
Immunolocalization of kisspeptin associated with amyloid-β deposits in the pons of an Alzheimer’s disease patient (2013)
Chilumuri, A., Ashioti, M., Nercessian, A.N. and Milton, N.G.N. 2013. Immunolocalization of kisspeptin associated with amyloid-β deposits in the pons of an Alzheimer’s disease patient. Journal of Neurodegenerative Diseases. 2013, p. Article ID 879710.

2012

Kisspeptin prevention of Amyloid-β Peptide neurotoxicity in vitro (2012)
Milton, N.G.N., Chilumuri, A., Rocha-Ferreira, E., Nercessian, A.N. and Ashioti, M. 2012. Kisspeptin prevention of Amyloid-β Peptide neurotoxicity in vitro. ACS chemical neuroscience. 3 (9), pp. 706-719.

2009

Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT1A agonist in rat models of ischaemic stroke (2009)
Ashioti, M., Beech, J.S., Lowe, A.S., Bernanos, M., McCreary, A., Modo, M.M. and Williams, S.C.R. 2009. Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT1A agonist in rat models of ischaemic stroke. BMC Neuroscience. 10 (82).

2013

Neuroprotective efficacy of the endogenous neuropeptide Urocortin in a oxygen-glucose deprivation model of transient cerebral ischaemia with reperfusion (2013)
Ashioti, M., Getting, S.J., Locke, I.C. and Milton, N.G.N. 2013. Neuroprotective efficacy of the endogenous neuropeptide Urocortin in a oxygen-glucose deprivation model of transient cerebral ischaemia with reperfusion. British Neuroscience Association 22nd Biennial Meeting. London 7th-10th April 2013

Browse

Browse our directory to find staff profiles containing contact information, biography and list of publications.

Related links

Research strategy
Our University

Discover how the University of Westminster is organised and who makes the University tick.